Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER

Overview of attention for article published in European Journal of Heart Failure, March 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 36 X posts from 36 X users, with an upper bound of 60,391 followers.

RT @ZHeart11768530: 🔴 Dapagliflozin in pts with #HF & previous #MI: A participant-level pooled analysis of DAPA-HF & DELIVER #openaccess…

RT @ZHeart11768530: 🔴 Dapagliflozin in pts with #HF & previous #MI: A participant-level pooled analysis of DAPA-HF & DELIVER #openaccess…

RT @mvaduganathan: New data in @ESC_Journals #EJHF from #DAPAHF & #DELIVER by @PeikertA #SGLT2i dapagliflozin shows consistent protection…

RT @Office_j: 【DAPA-HF、DALIVER併合解析/ EJHF】 MI既往例の割合はHFrEFの44%、pEFで26%。SGLT2-iによる「CV死亡・HF入院/増悪」リスク抑制はMI既往の有無に影響受けず。またMI既往の有無は、開始時EFの高低別に見たSG…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 32 additional X posts.